Biotech continues to outperform on a trailing 5 day basis versus the universe of ETFs we track. Today, the release of the Senate’s version of repeal for the ACA is helping push healh care higher, and biotech is receving some of the benefit along with Pharma stocks and Health Care more broadly. Chinese ETFs have risen, as while bonds continue to outperform as well. On the losing side of the slate, retail, banking, and commodities are undeperformers along with a smattering of EM equity ETFs.
Bespoke provides Bespoke Premium and Bespoke Institutional members with a daily ETF Trends report that highlights proprietary trend and timing scores for more than 200 widely followed ETFs across all asset classes. If you’re an ETF investor, this daily report is perfect. Sign up below to access today’s ETF Trends report.
See Bespoke’s full daily ETF Trends report by starting a no-obligation free trial to our premium research. Click here to sign up with just your name and email address.